Drug intelligence / Profile preview

alder + birch + hazel pollen extract

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Alder + birch + hazel pollen extract is a combination of allergenic extracts used for allergen-specific immunotherapy (AIT) to treat tree pollen-induced allergic rhinitis and asthma. This therapy works by administering gradually increasing doses of the pollen extracts to the patient, which desensitizes their immune system to the specific allergens from alder, birch, and hazel trees. A three-year double-blind clinical study demonstrated that this combination extract was effective, reducing symptom scores to one-tenth of the initial level and increasing pollen tolerance by thirty-fold. The mechanism involves modulating the immune response from a Th2-driven allergic reaction towards a tolerant state, characterized by the induction of regulatory T cells (Tregs) and a shift in antibody production from IgE to blocking antibodies like IgG4.

Other names
partially purified and standardized tree pollen extracts

Beyond the preview

Go deeper on alder + birch + hazel pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alder + birch + hazel pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call